1. IFNL4 Genotypes and Risk of Childhood Burkitt Lymphoma in East Africa.
- Author
-
Baker, Francine, Wang, Jeanny, Florez-Vargas, Oscar, Brand, Nathan, Ogwang, Martin, Kerchan, Patrick, Reynolds, Steven, Tenge, Constance, Were, Pamela, Kuremu, Robert, Wekesa, Walter, Masalu, Nestory, Kawira, Esther, Kinyera, Tobias, Otim, Isaac, Legason, Ismail, Nabalende, Hadijah, Chagaluka, George, Mutalima, Nora, Borgstein, Eric, Liomba, George, Kamiza, Steve, Mkandawire, Nyengo, Mitambo, Collins, Molyneux, Elizabeth, Newton, Robert, Prokunina-Olsson, Ludmila, and Mbulaiteye, Sam
- Subjects
Burkitt Lymphoma ,IFNL4 ,genetic susceptibility ,infection ,interferon Lambda 4 ,Child ,Preschool ,Child ,Humans ,Burkitt Lymphoma ,Genotype ,Hepatitis C ,Hepacivirus ,Africa ,Eastern ,Interleukins ,Polymorphism ,Single Nucleotide - Abstract
Interferon lambda 4 (IFN-λ4) is a novel type-III interferon that can be expressed only by carriers of the genetic variant rs368234815-dG within the first exon of the IFNL4 gene. Genetic inability to produce IFN-λ4 (in carriers of the rs368234815-TT/TT genotype) has been associated with improved clearance of hepatitis C virus (HCV) infection. The IFN-λ4-expressing rs368234815-dG allele (IFNL4-dG) is most common (up to 78%) in West sub-Saharan Africa (SSA), compared to 35% of Europeans and 5% of individuals from East Asia. The negative selection of IFNL4-dG outside Africa suggests that its retention in African populations could provide survival benefits, most likely in children. To explore this hypothesis, we conducted a comprehensive association analysis between IFNL4 genotypes and the risk of childhood Burkitt lymphoma (BL), a lethal infection-associated cancer most common in SSA. We used genetic, epidemiologic, and clinical data for 4,038 children from the Epidemiology of Burkitt Lymphoma in East African Children and Minors (EMBLEM) and the Malawi Infections and Childhood Cancer case-control studies. Generalized linear mixed models fit with the logit link controlling for age, sex, country, P. falciparum infection status, population stratification, and relatedness found no significant association between BL risk and 3 coding genetic variants within IFNL4 (rs368234815, rs117648444, and rs142981501) and their combinations. Because BL occurs in children 6-9 years of age who survived early childhood infections, our results suggest that additional studies should explore the associations of IFNL4-dG allele in younger children. This comprehensive study represents an important baseline in defining the health effects of IFN-λ4 in African populations.
- Published
- 2023